AstraZeneca has funded an RSV surveillance dashboard run by the non-profit organisation ReSViNET, based in the Netherlands, to collect data from 20 countries. The dashboard will collect data from 20 countries on the prevalence and severity of RSV in the community. It will be important to have multiple RSV antibodies on the market to increase…